ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,425,000 | -93.5% | 384,995 | -88.7% | 0.21% | -92.1% |
Q2 2021 | $83,155,000 | +147.5% | 3,409,410 | +161.8% | 2.61% | +154.0% |
Q1 2021 | $33,595,000 | -58.9% | 1,302,129 | -14.9% | 1.03% | -64.3% |
Q4 2020 | $81,765,000 | +370.7% | 1,529,474 | +263.2% | 2.88% | +258.3% |
Q3 2020 | $17,370,000 | +86.4% | 421,087 | +43.4% | 0.80% | +268.3% |
Q4 2014 | $9,321,000 | -32.9% | 293,565 | -47.7% | 0.22% | -31.9% |
Q3 2014 | $13,885,000 | -62.3% | 560,786 | -65.6% | 0.32% | -56.6% |
Q2 2014 | $36,871,000 | -3.1% | 1,632,175 | +4.4% | 0.74% | +6.8% |
Q1 2014 | $38,038,000 | – | 1,563,435 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |